Hören Sie monatlich Experten, die Artikel aus JCO Precision Oncology besprechen, moderiert von Dr. Abdul Rafeh Naqash. Informieren Sie sich über Neuigkeiten in der Krebsbehandlung.
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
23 mins • Dec 18, 2024
Charts
- 198Decreased by 43
- 124Decreased by 1
- 109Decreased by 21
- 22Decreased by 8
Neueste Folgen
Dec 18, 2024
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
23 mins
Nov 27, 2024
JCO Precision Oncology Article Insights: Germline Pathogenic Variants in Renal Cell Carcinoma
10 mins
Nov 15, 2024
Uptake of Aspirin Chemoprevention in Lynch Syndrome
31 mins
Oct 30, 2024
JCO PO Article Insights: Talazoparib in Solid Tumors with BRCA1/2 Mutation
7 mins
Oct 16, 2024
Transcriptomic Profiling of Non-Localized Prostate Cancer
27 mins
Sprache
Englisch
Land
Kolumbien
Feed Host
Website
Feed